These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31079238)

  • 1. In vivo electrophysiological recordings of the effects of antidepressant drugs.
    Fitzgerald PJ; Watson BO
    Exp Brain Res; 2019 Jul; 237(7):1593-1614. PubMed ID: 31079238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
    J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks.
    Amat-Foraster M; Jensen AA; Plath N; Herrik KF; Celada P; Artigas F
    Neuropharmacology; 2018 Jul; 137():13-23. PubMed ID: 29702122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.
    Nagy D; Stoiljkovic M; Menniti FS; Hajós M
    Neuropsychopharmacology; 2016 May; 41(6):1486-94. PubMed ID: 26404843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism at the NR2B subunit of NMDA receptors induces increased connectivity of the prefrontal and subcortical regions regulating reward behavior.
    Gass N; Becker R; Sack M; Schwarz AJ; Reinwald J; Cosa-Linan A; Zheng L; von Hohenberg CC; Inta D; Meyer-Lindenberg A; Weber-Fahr W; Gass P; Sartorius A
    Psychopharmacology (Berl); 2018 Apr; 235(4):1055-1068. PubMed ID: 29305627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of mTOR in depression and antidepressant responses.
    Abelaira HM; Réus GZ; Neotti MV; Quevedo J
    Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine Alters Lateral Prefrontal Oscillations in a Rule-Based Working Memory Task.
    Ma L; Skoblenick K; Johnston K; Everling S
    J Neurosci; 2018 Mar; 38(10):2482-2494. PubMed ID: 29437929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine induced converged synchronous gamma oscillations in the cortico-basal ganglia network of nonhuman primates.
    Slovik M; Rosin B; Moshel S; Mitelman R; Schechtman E; Eitan R; Raz A; Bergman H
    J Neurophysiol; 2017 Aug; 118(2):917-931. PubMed ID: 28468999
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
    Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM
    Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.
    Amat-Foraster M; Celada P; Richter U; Jensen AA; Plath N; Artigas F; Herrik KF
    Neuropharmacology; 2019 Nov; 158():107745. PubMed ID: 31445017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats.
    Becker R; Gass N; Kußmaul L; Schmid B; Scheuerer S; Schnell D; Dorner-Ciossek C; Weber-Fahr W; Sartorius A
    Psychopharmacology (Berl); 2019 Dec; 236(12):3451-3463. PubMed ID: 31267156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Low Doses of Ketamine on Pyramidal Neurons in Rat Prefrontal Cortex.
    Shen G; Han F; Shi WX
    Neuroscience; 2018 Aug; 384():178-187. PubMed ID: 29859979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta and Gamma Oscillations in Prefrontal Cortex During NMDA Hypofunction: An In Vitro Model of Schizophrenia Features.
    Rebollo B; Perez-Zabalza M; Ruiz-Mejias M; Perez-Mendez L; Sanchez-Vives MV
    Neuroscience; 2018 Jul; 383():138-149. PubMed ID: 29723576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on NMDA antagonists in depression.
    Pochwat B; Nowak G; Szewczyk B
    Expert Rev Neurother; 2019 Nov; 19(11):1055-1067. PubMed ID: 31328587
    [No Abstract]   [Full Text] [Related]  

  • 15. Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801.
    Lemercier CE; Holman C; Gerevich Z
    Schizophr Res; 2017 Oct; 188():118-124. PubMed ID: 28109667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of antidepressant drugs in GPR39 (zinc receptor⁻/⁻) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists.
    Młyniec K; Gaweł M; Nowak G
    Behav Brain Res; 2015; 287():135-8. PubMed ID: 25827929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine and phencyclidine: the good, the bad and the unexpected.
    Lodge D; Mercier MS
    Br J Pharmacol; 2015 Sep; 172(17):4254-76. PubMed ID: 26075331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational NMDA receptor modulators for depression.
    Szewczyk B; Pałucha-Poniewiera A; Poleszak E; Pilc A; Nowak G
    Expert Opin Investig Drugs; 2012 Jan; 21(1):91-102. PubMed ID: 22097925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish.
    Opler LA; Opler MG; Arnsten AF
    CNS Spectr; 2016 Feb; 21(1):12-22. PubMed ID: 25619798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive
    Witkin JM; Mitchell SN; Wafford KA; Carter G; Gilmour G; Li J; Eastwood BJ; Overshiner C; Li X; Rorick-Kehn L; Rasmussen K; Anderson WH; Nikolayev A; Tolstikov VV; Kuo MS; Catlow JT; Li R; Smith SC; Mitch CH; Ornstein PL; Swanson S; Monn JA
    J Pharmacol Exp Ther; 2017 Apr; 361(1):68-86. PubMed ID: 28138040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.